Back to Results
First PageMeta Content
Drug discovery / Orphan drug / Pharmaceuticals policy / Pharmacology / Orphan Drug Act / Rare disease / Eisai / Food and Drug Administration / Canadian Organization for Rare Disorders / Health / Pharmaceutical sciences / Clinical research


Microsoft PowerPoint - 4. Beakes Read Considerations for Global Development of Drugs for Rare Diseases3 [互換モード]
Add to Reading List

Document Date: 2012-07-24 08:38:56

Open Document

File Size: 76,75 KB

Share Result on Facebook

City

Phillipines / /

Company

Eisai Inc. / Intelligence Eisai Inc. / /

Continent

Europe / /

Country

Taiwan / Egypt / Thailand / Indonesia / Malaysia / Japan / Russia / United States / Saudi Arabia / Brazil / Panama / Canada / Australia / Korea / China / Singapore / Israel / Argentina / Mexico / Lebanon / Peru / /

IndustryTerm

rare disease products / /

MedicalCondition

rare diseases / rare disease / chronic progressing diseases / Defines Rare Diseases / diseases / /

Organization

Speakers Bureau / FDA / European Union / Ministry of Health / /

Position

Orphan Drugs Ginny Beakes-Read Executive Director Global Regulatory Policy / Consultant / /

Region

Middle East / /

Technology

Drug Development / /

SocialTag